What is the intrinsic value of Bmy?

As of 2025-06-29, the Intrinsic Value of Bristol-Myers Squibb Co (BMY) is 13.31 USD. This Bmy valuation is based on the model Peter Lynch Fair Value. With the current market price of 46.35 USD, the upside of Bristol-Myers Squibb Co is -71.28%.

Is Bmy undervalued or overvalued?

Based on its market price of 46.35 USD and our intrinsic valuation, Bristol-Myers Squibb Co (BMY) is overvalued by 71.28%.

	Range	Selected	Upside
a
DCF (Growth 5y)	(878.85) - (81.56)	(131.78)	-384.3%
DCF (Growth 10y)	(78.88) - (762.13)	(122.14)	-363.5%
DCF (EBITDA 5y)	(39.99) - (42.59)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(45.57) - (49.31)	(1,234.50)	-123450.0%
Fair Value	13.31 - 13.31	13.31	-71.28%
P/E	53.79 - 76.05	61.98	33.7%
EV/EBITDA	52.05 - 157.83	90.59	95.4%
EPV	163.41 - 221.21	192.31	314.9%
DDM - Stable	36.87 - 226.84	131.86	184.5%
DDM - Multi	(47.90) - (206.06)	(75.30)	-262.5%